Vectorite Biomedical

Vectorite Biomedical LT Debt/Equity

Long-Term Debt to Equity Ratio of Vectorite Biomedical (4170.TWO) as of Nov 5, 2026.

LT Debt/Equity

0.00

Last updated:

Long-Term Debt to Equity Ratio of Vectorite Biomedical is 2018 0.00 . Long-Term Debt to Equity Ratio of Vectorite Biomedical was 2017 0.00 . It decreases by % lower compared to the previous year.

The Vectorite Biomedical LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2014
0.00 TWD
Jan 1, 2015
0.06 TWD
Jan 1, 2016
0.00 TWD
Jan 1, 2017
0.00 TWD
Jan 1, 2018
0.00 TWD
The Vectorite Biomedical LT Debt/Equity history
YEARLT Debt/EquityYoY
0.00—
0.00—
0.00-100.00%
0.06—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Xinpin Biomedical Co., Ltd. established Xinpin Biomedical Group with the concept of “preventing problems before it happens” and is headquartered in Taipei, New Taipei. The firm offers a range of services including immune cell collection, processing and storage, cell preparation safety testing, anti-cancer immunity testing, original design manufacturer or contract development and manufacturing organization services, related medical consulting, and laboratory quality management. Its product portfolio features dendritic cell vaccines and natural killer cell preparations designed for cancer treatment. Products are mainly sold domestically. Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's Vectorite Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Vectorite Biomedical

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Vectorite Biomedical